Suppr超能文献

基于锥形束CT的放疗期间前列腺运动和剂量畸变估计

Cone-beam CT-based estimations of prostate motion and dose distortion during radiotherapy.

作者信息

Klucznik Karolina A, Ravkilde Thomas, Skouboe Simon, Møller Ditte S, Hokland Steffen, Keall Paul, Buus Simon, Bentzen Lise, Poulsen Per R

机构信息

Danish Centre for Particle Therapy, Aarhus University Hospital, Aarhus, Denmark.

Department of Oncology, Aarhus University Hospital, Aarhus, Denmark.

出版信息

Phys Imaging Radiat Oncol. 2025 Jun 24;35:100798. doi: 10.1016/j.phro.2025.100798. eCollection 2025 Jul.

Abstract

BACKGROUND AND PURPOSE

Intra-fractional prostate translational and rotational (6DoF) motion can cause dose distortions. As intra-fractional motion monitoring is often unavailable, this study compares three methods to use pre- and post-treatment cone beam CTs (CBCT) to estimate prostate positioning errors during treatment and their dosimetric impact.

MATERIAL AND METHODS

Eighteen patients received prostate radiotherapy with pre-treatment CBCT setup. For 7-10 fractions per patient (total:174), triggered kV-images were acquired every 3 s during beam-on and a CBCT was acquired post-treatment. The 6DoF prostate position error during treatment was determined from the kV-images (ground truth) and estimated from the CBCTs assuming a static position as in the pre-CBCT(Scenario1), a linear drift between pre- and post-CBCT position(Scenario2) or a static position as in the post-CBCT(Scenario3). The positioning errors and prostate dose from each scenario were compared with the ground truth.

RESULTS

Scenario1 was inferior to the others with prostate position root-mean-square errors of 1.1 mm(LR), 1.7 mm(AP) and 1.8 mm(CC). Scenario2 and 3 were similarly accurate with root-mean-square errors of 0.5 mm(LR), 0.9 mm(AP) and 0.8 mm(CC) (Scenario2) and 0.6 mm(LR), 1.1 mm(AP) and 0.9 mm(CC) (Scenario3). The prostate position errors reduced the CTV D by more than 2/3 % at 24/15 % of the fractions, respectively. The sensitivity in detecting these dose deficits was low for Scenario1 (9-16 %) and considerably higher for Scenario2 (68-76 %) and Scenario3 (86-91 %). All scenarios showed high specificity (93-99 %).

CONCLUSION

Using the post-CBCT prostate position, acquired right after treatment, performed best in detecting intra-fractional prostate position errors and CTV dose deficits. It offers a scalable and conservative estimate of motion-induced dose distortions.

摘要

背景与目的

分次治疗期间前列腺的平移和旋转(6自由度)运动会导致剂量畸变。由于通常无法进行分次治疗期间的运动监测,本研究比较了三种利用治疗前和治疗后锥束CT(CBCT)来估计治疗期间前列腺定位误差及其剂量学影响的方法。

材料与方法

18例患者接受了基于治疗前CBCT设置的前列腺放疗。每位患者进行7 - 10次分次治疗(共174次),在射束开启期间每3秒采集一次触发千伏图像,并在治疗后采集一次CBCT。治疗期间的6自由度前列腺位置误差由千伏图像确定(真实情况),并根据CBCT估计,假设为CBCT前的静态位置(方案1)、CBCT前后位置的线性漂移(方案2)或CBCT后的静态位置(方案3)。将每种方案的定位误差和前列腺剂量与真实情况进行比较。

结果

方案1不如其他方案,前列腺位置的均方根误差为左右方向(LR)1.1毫米、前后方向(AP)1.7毫米和头脚方向(CC)1.8毫米。方案2和方案3同样准确,均方根误差分别为左右方向0.5毫米、前后方向0.9毫米和头脚方向0.8毫米(方案2)以及左右方向0.6毫米、前后方向1.1毫米和头脚方向0.9毫米(方案3)。前列腺位置误差分别在24%/15%的分次治疗中使临床靶体积(CTV)剂量降低超过2/3%。方案1检测这些剂量不足的敏感性较低(9 - 16%),而方案2(68 - 76%)和方案3(86 - 91%)的敏感性则高得多。所有方案均显示出高特异性(93 - 99%)。

结论

使用治疗后立即采集的CBCT前列腺位置,在检测分次治疗期间前列腺位置误差和CTV剂量不足方面表现最佳。它提供了一种可扩展且保守的运动诱导剂量畸变估计。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/58b9/12269408/d77c61bffb03/gr1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验